Conformis,Inc. (NASDAQ:CFMS) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07
Submission of Matters to a Vote of Security Holders
Conformis,Inc. (NASDAQ:CFMS) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07
Submission of Matters to a Vote of Security Holders
Conformis, Inc. (the “Company”) held its Annual Meeting of Stockholders on April 30, 2018. The following is a summary of the matters voted on at that meeting.
1. |
The Company’s stockholders elected Kenneth Fallon, III and Bradley Langdale as class III directors to serve until the 2021 Annual Meeting of Stockholders or until their respective successors have been duly elected and qualified. The results of the stockholders’ vote with respect to the election of such class III directors were as follows: |
Votes For |
Votes Withheld |
Broker Non-Votes |
|
Kenneth Fallon, III |
19,593,802 |
5,162,871 |
14,158,118 |
Bradley Langdale |
20,598,808 |
4,157,865 |
14,158,118 |
2. |
The Company’s stockholders ratified the selection of Grant Thornton LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018. The results of the stockholders’ vote with respect to such ratification were as follows: |
Votes For |
Votes Against |
Votes Abstaining |
Broker Non-Votes |
38,017,123 |
565,197 |
332,471 |
About Conformis,Inc. (NASDAQ:CFMS)
ConforMIS, Inc. is a medical technology company that uses its iFit Image-to-Implant technology platform to develop, manufacture and sell joint replacement implants. The Company’s products include iTotal CR, which is the cruciate-retaining, customized total knee replacement system to restore the natural shape of a patient’s knee; iTotal PS, which is the posterior cruciate ligament substituting, or posterior-stabilized, customized total knee replacement product to restore the natural shape of a patient’s knee; iDuo, which is the customized bicompartmental knee replacement system, and iUni, which is the customized unicompartmental knee replacement product for treatment of the medial or lateral compartment of the knee. Its iFit technology platform comprises three elements: iFit Design, iFit Printing and iFit Just-in-Time Delivery. The Company markets and sells its products in the United States, Germany, the United Kingdom, Austria, Ireland, Switzerland, Singapore and Hong Kong.